Stock listing

Avalo Therapeutics, Inc.

Selected listing: C6K0 · MUN · EUR · DE

Avalo Therapeutics, Inc. (Munich:C6K0), Health Technology. Latest release Sep 29, 2026: Avalo Therapeutics Announces Inducement Grants to New Employees Under…

C6K0:MUNEURDEUpdated October 2, 2026

Ticker: Munich:C6K0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Avalo Therapeutics, Inc.

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

September 28, 2026

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

September 23, 2026

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

August 6, 2026

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

July 22, 2026

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

July 7, 2026

All Avalo Therapeutics, Inc. news →

Events

Replays

Avalo Therapeutics, Inc. (AVTX) Q3 2024 Earnings Call
Wed, Oct 30, 2024 · 09:00 AM ET
Watch
Avalo Therapeutics, Inc. (AVTX) Q2 2024 Earnings Call
Wed, Jul 31, 2024 · 09:00 AM ET
Watch
Avalo Therapeutics, Inc. (AVTX) Q1 2024 Earnings Call
Wed, May 01, 2024 · 09:00 AM ET
Watch

Research Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. company profile

View the public company page for Avalo Therapeutics, Inc. on 6ix.

Avalo Therapeutics, Inc. news

Read company news and market updates connected to Avalo Therapeutics, Inc..

Avalo Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Avalo Therapeutics, Inc..